Sign in

Loews Corporation L

Price 110.0 USD
as of 2026-09-05
53/100
Weak
Quality44
Growth54
Balance-sheet strength44
Valuation78
Momentum49
Income36

Composite 53/100; the shares have moved about 18% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Income ranks 36/100 — a moderate mark against it.

Case for

Valuation ranks 78/100 — a strong point in its favour. Growth ranks 54/100 — a slight point in its favour.

Case against

Income ranks 36/100 — a moderate mark against it. Quality ranks 44/100 — a slight mark against it. Balance-sheet strength ranks 44/100 — a slight mark against it.

What the company does Loews Corporation, through its subsidiaries, provides commercial property and casualty insurance in the U.S. and internationally, offering specialty products such as management liability, surety bonds, and cyber coverages for professional firms and healthcare providers.

Key financials Loews reports ROE of 9.3%, ROA of 1.9%, and net margins of 9.0%. Revenue grew 3.9% while EPS rose 15.6%. Debt/Equity stands at 0.45 with a net debt/EBITDA of 0.78 and a current ratio of 0.51.

Stock health The stock shows mixed momentum: +7.51% over 3m, +2.86% over 6m, +18.75% over 12m, and -6.59% below its 52w high. RSI(14) is 42.10, indicating neutral momentum.

Price vs fair value The stock trades at a PREMIUM of 46.90% versus the analyst mean target of 60.00. - Trading at a premium to the analyst mean target (Valuation anchor) - Sideravia Valuation percentile of 68.4/100 suggests above-average valuation - Low dividend yield of 0.2% and payout of 3.1% may limit income appeal (Dividend yield, payout)

Looking forward Forward P/E of 12.20 and PEG of 0.88 suggest reasonable earnings growth expectations, but high premium to fair value and modest profitability metrics may cap near-term upside.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.